| 5 | Sleep impairment in ecstasy/polydrug and cannabis-only users.
| ADAI/UW Link |
| 6 | The spatial epidemiology of cocaine, methamphetamine and 3,4-methylenedioxymethamphetamine (MDMA) use: a demonstration using a population measure of community drug load derived from municipal wastewater.
| UW Link |
| 7 | The development and validation of the methylenedioxymethamphetamine (MDMA) beliefs questionnaire (MDMA-BQ) in college students.
| ADAI/UW Link |
| 8 | Methylenedioxymethamphetamine (MDMA)-related fatalities in Australia: demographics, circumstances, toxicology and major organ pathology.
| UW Link |
| 9 | Movement disorders and MDMA abuse.
| UW Link |
| 10 | Young adult ecstasy users' enhancement of the effects of their ecstasy use.
| UW Link |
| 11 | The high prevalence of substance use disorders among recent MDMA users compared with other drug users: Implications for intervention.
| UW Link |
| 12 | Hallucinogen-related disorders in a national sample of adolescents: the influence of ecstasy/MDMA use.
| UW Link |
| 13 | MDMA powder, pills and crystal: the persistence of ecstasy and the poverty of policy.
| |
| 14 | What's in a label? Ecstasy sellers' perceptions of pill brands.
| UW Link |
| 15 | Mediating MDMA-related harm: preloading and post-loading among Ecstasy-using youth.
| UW Link |
| 16 | Condom use self-efficacy among young adult ecstasy users.
| UW Link |
| 17 | The association of ecstasy use and academic achievement among adolescents in two U.S. national surveys.
| UW Link |
| 18 | Factors associated with driving under the influence of alcohol and drugs among an Australian sample of regular ecstasy users.
| UW Link |
| 19 | Human psychopharmacology of ecstasy (MDMA): A review of 15 years of empirical research.
Parrott AC
Hum Psychopharmacol Clin Exp 2001;16:557-577 (Reprint 09822) [ ] | |
| 20 | Hallucinogen use disorders among adult users of MDMA and other hallucinogens.
| ADAI/UW Link |
| 21 | Signal-averaged electrocardiogram in physically healthy, chronic 3,4-methylenedioxymethamphetamine (MDMA) users.
| ADAI/UW Link |
| 22 | Tri-city study of Ecstasy use problems: a latent class analysis.
| UW Link |
| 23 | Self-reported psychopathology among young, low-income, female ecstasy users.
| ADAI/UW Link |
| 24 | Young adult Ecstasy users and multiple sexual partners: understanding the factors underlying this HIV risk practice.
| UW Link |
| 25 | MDMA-assisted psychotherapy using low doses in a small sample of women with chronic posttraumatic stress disorder.
| UW Link |
| 26 | Understanding recreational ecstasy use in the United States: A qualitative inquiry.
| UW Link |
| 27 | 'The great unmentionable': Exploring the pleasures and benefits of ecstasy from the perspectives of drug users.
Hunt GP ; Evans K
Drugs Educ Prev Policy 2008;15(4):329-349 (Journal) [ ] | ADAI/UW Link |
| 28 | Maximising the highs and minimising the lows: Harm reduction guidance within ecstasy distribution networks.
| UW Link |
| 29 | Fear, rationality and opportunity: Reasons and motives for not trying ecstasy.
| ADAI/UW Link |
| 30 | Predicting ecstasy use among young people at risk: a prospective study of initially ecstasy-naive subjects.
| UW Link |
| 31 | Ecstasy analogues found in cacti.
| UW Link |
| 32 | Past 12-month and lifetime comorbidity and poly-drug use of ecstasy users among young adults in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions.
| UW Link |
| 33 | Trends in ecstasy use in the United States from 1995-2001: comparison with marijuana users and association with other drug use.
Martins SS ; Mazzotti G ; Chilcoat HD
IN: Marlatt GA ; Witkiewitz K (eds.). ADDICTIVE BEHAVIORS: NEW READINGS ON ETIOLOGY, PREVENTION, AND TREATMENT. Washington, D.C.: American Psychological Association, 2009, pp.117-134 (Chapter) [Call No: RC 564 A314 2009] [ ] | |
| 34 | Reward-related decision-making deficits and elevated impulsivity among MDMA and other drug users.
| UW Link |
| 35 | Effects of priming injections of MDMA and cocaine on reinstatement of MDMA- and cocaine-seeking in rats.
| UW Link |
| 36 | Adolescent ecstasy and other drug use in the National Survey of Parents and Youth: the role of sensation-seeking, parental monitoring and peer's drug use.
| UW Link |
| 37 | Crystal methamphetamine smoking among regular ecstasy users in Australia: increases in use and associations with harm.
| UW Link |
| 38 | "I'm not a real dealer:" The identity process of ecstasy sellers.
| UW Link |
| 39 | Poly-drug use among ecstasy users: Separate, synergistic, and indiscriminate patterns.
| UW Link |
| 40 | The role of peers in the initiation and continuation of ecstasy use.
| ADAI/UW Link |
| 41 | Driving under the influence of central stimulant amines: age and gender differences in concentrations of amphetamine, methamphetamine, and ecstasy in blood.
| ADAI/UW Link |
| 42 | Use of specific hallucinogens: 2006.
| Free Link |
| 43 | High suicide risk after the development of cognitive and working memory deficits caused by cannabis, cocaine and ecstasy use.
| ADAI/UW Link |
| 44 | The effects of perceived quality on the behavioural economics of alcohol, amphetamine, cannabis, cocaine, and ecstasy purchases.
| UW Link |
| 45 | Do adolescent ecstasy users have different attitudes towards drugs when compared to marijuana users?
| UW Link |
| 46 | Social cognitive determinants of ecstasy use to target in evidence-based interventions: a meta-analytical review.
| UW Link |
| 47 | Pathways to ecstasy use in young adults: Anxiety, depression or behavioural deviance?
| UW Link |
| 48 | Searching the Internet for drug-related web sites: analysis of online available information on ecstasy (MDMA).
| ADAI/UW Link |
| 49 | Diffusion tensor imaging in MDMA users and controls: association with decision making.
| ADAI/UW Link |
| 50 | San Francisco's freelancing ecstasy dealers: Towards a sociological understanding of drug markets.
| UW Link |
| 51 | A psycho-economic model of ecstasy consumption and related consequences: a multi-site study with community samples.
| ADAI/UW Link |
| 52 | Making informed decisions : How attitudes and perceptions affect the use of crystal, cocaine, and ecstasy among young men who have sex with men.
| UW Link |
| 53 | Low hospital admission rates following MDMA (Ecstasy) intake in Essen (Germany).
| ADAI/UW Link |
| 54 | Monitoring ecstasy content in France: results from the national surveillance system 1999-2004.
| ADAI/UW Link |
| 55 | Polysubstance use and its correlates in adolescent ecstasy users in Taiwan.
| UW Link |
| 56 | Getting into ecstasy: comparing moderate and heavy young adult users.
| UW Link |
| 57 | How to find future ecstasy-users: targeted and snowball sampling in an ethically sensitive context.
| UW Link |
| 58 | Pathways between ecstasy initiation and other drug use.
| UW Link |
| 59 | Combined immunomodulating properties of 3,4-methylenedioxymethamphetamine (MDMA) and cannabis in humans.
| UW Link |
| 60 | The effects of price and perceived quality on the behavioural economics of alcohol, amphetamine, cannabis, cocaine, and ecstasy purchases.
| UW Link |
| 61 | Is recreational ecstasy (MDMA) use associated with higher levels of depressive symptoms? [Review]
| UW Link |
| 62 | Cognitive performance in light current users and ex-users of ecstasy (MDMA) and controls.
| ADAI/UW Link |
| 63 | Performance enhancement and adverse consequences of MDMA.
| |
| 64 | MDMA, methamphetamine and their combination: possible lessons for party drug users from recent preclinical research.
| UW Link |
| 65 | Anxiety, depression, and behavioral symptoms of executive dysfunction in ecstasy users: Contributions of polydrug use.
| UW Link |
| 66 | Repeated weekly exposure to MDMA, methamphetamine or their combination: Long-term behavioural and neurochemical effects in rats.
| UW Link |
| 67 | Ecstasy toxicity: a comparison to methamphetamine and traumatic brain injury.
| ADAI/UW Link |
| 68 | Stimulant effects of 3,4-methylenedioxymethamphetamine (MDMA) 75 mg and methylphenidate 20 mg on actual driving during intoxication and withdrawal.
| UW Link |
| 69 | Incidence and patterns of polydrug use and craving for ecstasy in regular ecstasy users: An ecological momentary assessment study.
| UW Link |
| 70 | Reflections on the development and implementation of an early warning system for ecstasy and related drug markets in Australia.
| UW Link |
| 71 | An extended nondrug MDMA-like experience evoked through posthypnotic suggestion.
| UW Link |
| 72 | A survey of regular ecstasy users' knowledge and practices around determining pill content and purity: Implications for policy and practice.
| UW Link |
| 73 | Long-term ecstasy use and the management of work and relationships.
| UW Link |
| 74 | An evaluation of a brief motivational intervention among young ecstasy and cocaine users: no effect on substance and alcohol use outcomes.
| UW Link |
| 75 | A review of the acute subjective effects of MDMA/ecstasy.
| UW Link |
| 76 | The origin of MDMA (ecstasy) revisited: the true story reconstructed from the original documents.
| UW Link |
| 77 | Impulsivity, inhibition and negative priming in ecstasy users.
| UW Link |
| 78 | Cognitive determinants of MDMA use among college students in Southern Taiwan.
| UW Link |
| 79 | Recreational ecstasy use and the neurotoxic potential of MDMA: current status of the controversy and methodological issues.
| UW Link |
| 80 | Party people: personality and MDMA use of house party visitors.
| UW Link |
| 81 | Chronic ecstasy (MDMA) use is associated with deficits in task-switching but not inhibition or memory updating executive functions.
| UW Link |
| 82 | Pharmacological content of tablets sold as “ecstasy”: results from an online testing service.
| UW Link |
| 83 | Prevalence of injecting drug use and associated risk behavior among regular ecstasy users in Australia.
| UW Link |
| 84 | Concurrent use of methamphetamine, MDMA, LSD, ketamine, GHB, and flunitrazepam among American youths.
| UW Link |
| 85 | Alcohol use and risk taking among regular ecstasy users.
| ADAI/UW Link |
| 86 | Patterns and perceptions of ecstasy use among young, low-income women.
| UW Link |
| 87 | Treatment implications for young adult users of MDMA.
| UW Link |
| 88 | Patterns of use and harm reduction practices of ecstasy users in Australia.
| UW Link |
| 89 | Hyperthermia induced by 3,4-methylenedioxymethamphetamine in unrestrained rhesus monkeys.
| UW Link |
| 90 | Neurotoxicity of methylenedioxyamphetamines (MDMA; ecstasy) in humans: how strong is the evidence for persistent brain damage?
| UW Link |
| 91 | Exploring the validity of self-reported Ecstasy use among club rave attendees.
| UW Link |
| 92 | Psychiatric disorders and their correlates among young adult MDMA users in Ohio.
| UW Link |
| 93 | A profile of Ecstasy (MDMA) use in Sao Paulo, Brazil: an ethnographic study.
| UW Link |
| 94 | Ecstasy (MDMA), methamphetamine, and date rape (drug-facilitated sexual assault): a consideration of the issues.
| UW Link |
| 95 | Ecstasy and the concomitant use of pharmaceuticals.
| UW Link |
| 96 | Prescription drug abuse among ecstasy users in Miami.
| ADAI/UW Link |
| 97 | Acute, sub-acute and long-term subjective consequences of 'ecstasy' (MDMA) consumption in 430 regular users.
| |
| 98 | Human psychopharmacology of Ecstasy (MDMA) : A review of 15 years of empirical research.
Parrott AC
Hum Psychopharmacol Clin Exp 2001;16:557-577 (Reprint 09534) [ ] | |
| 99 | Young adult ecstasy use patterns : Quantities and combinations.
| UW Link |
| 100 | The diffusion of ecstasy through urban youth networks.
| ADAI/UW Link |
| 101 | "Rollin' on E" : A qualitative analysis of ecstasy use among inner city adolescents and young adults.
| ADAI/UW Link |
| 102 | Prevalence and correlates of current depressive symptomatology among a community sample of MDMA users in Ohio.
| UW Link |
| 103 | Risk and benefit perceptions of party drug use.
| UW Link |
| 104 | Chronic treatment with a serotonin(2) receptor (5-HT(2)R) agonist modulates the behavioral and cellular response to (+)-3,4-methylenedioxymethamphetamine [(+)-MDMA].
| UW Link |
| 105 | Discriminative stimulus effects of 3,4-methylenedioxymethamphetamine (MDMA) in humans trained to discriminate among d-amphetamine, meta-chlorophenylpiperazine and placebo.
| UW Link |
| 106 | A clinical crossroads for MDMA.
| UW Link |
| 107 | Mental disorders in current and former heavy ecstasy (MDMA) users.
| UW Link |
| 108 | Pharmacological aspects of the combined use of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) and gamma-hydroxybutyric acid (GHB): a review of the literature.
| UW Link |
| 109 | Ecstasy and cocaine: patterns of use among prime age individuals in Amsterdam.
| UW Link |
| 110 | Mirtazepine for MDMA-induced depression.
| ADAI/UW Link |
| 111 | Drug use practices among MDMA/ecstasy users in Ohio: a latent class analysis.
| UW Link |
| 112 | Pathways into ecstasy use: the role of prior cannabis use and ecstasy availability.
| UW Link |
| 113 | Correlates of Ecstasy use in middle age and beyond.
| UW Link |
| 114 | Criminal involvement among young male ecstasy users.
| ADAI/UW Link |
| 115 | “Partying” hard: party style, motives for and effects of MDMA use at rave parties.
| ADAI/UW Link |
| 116 | MDMA and sexual behavior: ecstasy users' perceptions about sexuality and sexual risk.
| ADAI/UW Link |
| 117 | An in-depth qualitative examination of the ecstasy experience: results of a focus group with ecstasy-using college students.
| ADAI/UW Link |
| 118 | Ecstasy use among Hispanic and black substance users in New York City.
| ADAI/UW Link |
| 119 | High rates of club drug use and risky sexual practices among Hispanic men who have sex with men in Miami, Florida.
| ADAI/UW Link |
| 120 | Epidemiology of MDMA and associated club drugs in the Seattle area.
| ADAI/UW Link |
| 121 | Club drug use in Germany.
| ADAI/UW Link |
| 122 | Recent trends in the use of “club drugs”: an Australian review.
| ADAI/UW Link |
| 123 | Identifying the prevalence and correlates of ecstasy use among high school seniors surveyed through 2002 Monitoring the Future.
| UW Link |
| 124 | Gender differences among MDMA users on psychological and drug history variables.
| UW Link |
| 125 | Identifying the perceived and diagnosed prevalence of ecstasy dependence among club rave attendees.
| ADAI/UW Link |
| 126 | Ecstasy pill testing: harm minimization gone too far?
| UW Link |
| 127 | Use, abuse and dependence of ecstasy and related drugs in adolescents and young adults -- a transient phenomenon? Results from a longitudinal community study.
| UW Link |
| 128 | MDMA ('ecstasy') use, and its association with high risk behaviors, mental health, and other factors among gay/bisexual men in New York City.
| UW Link |
| 129 | Is ecstasy perceived to be safe? A critical survey.
| UW Link |
| 130 | Characteristics of ecstasy users in Sao Paulo, Brazil.
| ADAI/UW Link |
| 131 | Memory performance in polyvalent MDMA (ecstasy) users who continue or discontinue MDMA use.
| UW Link |
| 132 | Respondent-driven sampling to recruit MDMA users: a methodological assessment.
| UW Link |
| 133 | A comparison of the reinforcing efficacy of 3,4-methylenedioxymethamphetamine (MDMA, “ecstasy”) with cocaine in rhesus monkeys.
| UW Link |
| 134 | Exploring the temporal relationship between race and the use of ecstasy: Findings from the National Household Survey on Drug Abuse.
| ADAI/UW Link |
| 135 | Harm reduction and decision making among recreational ecstasy users.
| UW Link |
| 136 | A clash of policy approaches. The rise (and fall?) of Dutch harm reduction policies towards ecstasy consumption.
| UW Link |
| 137 | Rolling beyond raves : Ecstasy use outside the rave setting.
| UW Link |
| 138 | Mood and impulsivity of recreational ecstasy users in the week following a "rave."
| ADAI/UW Link |
| 139 | Designer drugs.
Morgan JP
In: Lowinson JH; Ruiz P; Millman RB; Langrod JG (eds.) SUBSTANCE ABUSE: A COMPREHENSIVE TEXTBOOK / 4th ed. -- Philadelphia: Lippincott, Williams & Wilkins, 2004. pp. 367-373 (Chapter) [Call No: RC 564 S826 2004 [REF HAND]] [ ] | |
| 140 | MDMA
Grob CS ; Poland RE
In: Lowinson JH; Ruiz P; Millman RB; Langrod JG (eds.) SUBSTANCE ABUSE: A COMPREHENSIVE TEXTBOOK / 4th ed. -- Philadelphia: Lippincott, Williams & Wilkins, 2004. pp. 374-386 (Chapter) [Call No: RC 564 S826 2004 [REF HAND]] [ ] | |
| 141 | Differential effects of MDMA, cocaine, and cannabis use severity on distinctive components of the executive functions in polysubstance users: a multiple regression analysis.
| UW Link |
| 142 | Young people, dance and the sub-culture consumption of drugs.
| ADAI/UW Link |
| 143 | "E" is for enterprise: Middle level drug markets in ecstasy and stimulants.
| ADAI/UW Link |
| 144 | Estimating the prevalence of ecstasy use among club rave attendees.
| UW Link |
| 145 | 3,4 methylenedioxymethamphetamine (Ecstasy) and symptoms of depression in the collegiate population. [letter]
Blowers JG
J Alcohol Drug Educ 2004;48(1):5-12 (Journal) [ ] | UW Link |
| 146 | The acute and sub-acute effects of 'ecstasy' (MDMA) on processing of facial expressions: preliminary findings.
| UW Link |
| 147 | Club drug use among minority substance users in New York City.
| |
| 148 | Acute toxic effects of club drugs.
| |
| 149 | Club drugs: reasons for and consequences of use.
| |
| 150 | Examining the prevalence and perceived harm of ecstasy and other drug use among juvenile offenders.
| ADAI/UW Link |
| 151 | Gender differences in self-reported anxiety, depression, and somatization among ecstasy/MDMA polydrug users, alcohol/tobacco users, and nondrug users.
| UW Link |
| 152 | Outcome expectancies and ecstasy use in visitors of rave parties in the Netherlands.
| ADAI/UW Link |
| 153 | Perceived adverse consequences associated with MDMA/Ecstasy use among young polydrug users in Ohio: Implications for intervention.
| UW Link |
| 154 | Toward an ecstasy and other club drug (EOCD) prevention intervention for rave attendees.
| UW Link |
| 155 | Have Halpern et al. (2004) detected 'residual neuropsychological effects' of MDMA? Not likely.
| UW Link |
| 156 | Residual neuropsychological effects of illicit 3,4-methylenedioxymethamphetamine (MDMA) in individuals with minimal exposure to other drugs.
| UW Link |
| 157 | A behavioural economic analysis of alcohol, amphetamine, cocaine and ecstasy purchases by polysubstance misusers.
| UW Link |
| 158 | Impulsivity, risk taking and recreational 'ecstasy' (MDMA) use.
| UW Link |
| 159 | Comparison of the discriminative stimulus effects of 3,4-methylenedioxymethamphetamine (MDMA) and cocaine: asymmetric generalization.
| UW Link |
| 160 | Psychosocial profiles of older adolescent MDMA users.
| UW Link |
| 161 | Ecstasy: commodity or disease?
| |
| 162 | MDMA/Ecstasy use among young people in Ohio: perceived risk and barriers to intervention.
| |
| 163 | Increased intensity of Ecstasy and polydrug usage in the more experienced recreational Ecstasy/MDMA users: a WWW study.
| UW Link |
| 164 | The external validity of results derived from ecstasy users recruited using purposive sampling strategies.
| UW Link |
| 165 | Baclofen prevents MDMA-induced rise in core body temperature in rats.
| UW Link |
| 166 | Sources of information about MDMA (3,4-methylenedioxymethamphetamine): perceived accuracy, importance, and implications for prevention among young adult users.
| UW Link |
| 167 | Patterns, trends, and meanings of drug use by dance-drug users in Edinburgh, Scotland.
| ADAI/UW Link |
| 168 | "Ordinary" people with "normal" lives? A longitudinal study of ecstasy and other drug use among Norwegian youth.
| UW Link |
| 169 | Tracking ecstasy trends in the United States with data from three national drug surveillance systems.
| UW Link |
| 170 | Ecstasy use in South Africa: findings from the South African Community Epidemiology Network on Drug Use (SACENDU) project (January 1997-December 2001).
| ADAI/UW Link |
| 171 | MDMA, ketamine, GHB, and the "club drug" scene.
McDowell DM
In: Galanter M ; Kleber HD (eds.). THE AMERICAN PSYCHIATRIC PUBLISHING TEXTBOOK OF SUBSTANCE ABUSE TREATMENT / 3rd ed. Washington, D.C. : American Psychiatric Publishing, Inc., 2004, pp. 321-333 (Chapter) [Call No: RC 564 A526 2004 [REF HAND]] [ ] | |
| 172 | A contextual profile of club drug use among adults in Chicago.
| UW Link |
| 173 | Factors associated with ecstasy use in Turkish students.
| UW Link |
| 174 | Patterns of ecstasy use in Australia: findings from a national household survey.
| UW Link |
| 175 | What all social workers should know about MDMA (ecstasy).
Harris G
J Social Work Pract Addict 2004;4(1):32-37 (Journal) [ ] | ADAI/UW Link |
| 176 | Reinforcing, subjective, and physiological effects of MDMA in humans: a comparison with d-amphetamine and mCPP.
| UW Link |
| 177 | Reduced cortical gray matter density in human MDMA (Ecstasy) users: a voxel-based morphometry study.
| UW Link |
| 178 | MDMA and harm; should ecstasy be kept on a restricted list?
Fitzgerald J
Int J Drug Policy 1991;2(4):22-24 (Journal) [ ] | |
| 179 | Ethnographic notes on ecstasy use among professionals.
| |
| 180 | Laing on ecstasy. [R. D. Laing]
Nasmyth P
Int J Drug Policy 1989;1(3):14-15 (Journal) [ ] | |
| 181 | The pharmacology and toxicology of "ecstasy" (MDMA) and related drugs.
Kalant H
Can Med Assoc J 2001;165(7):917-928 (Reprint 09169) [ ] | |
| 182 | MDMA (Ecstasy) : Clinical perspectives.
Mendelson J
In: Graham AW ; Schultz TK ; Mayo-Smith MF ; Ries RK ; Wilford BB (eds.) PRINCIPLES OF ADDICTION MEDICINE / 3rd ed. Chevy Chase, MD : American Society of Addiction Medicine, Inc., 1998, pp.191-192 (Chapter) [Call No: RC 564 M455 2003 [REF HAND]] [ ] | |
| 183 | The pharmacology of serotonergic hallucinogens and "designer drugs".
Glennon RA
In: Graham AW ; Schultz TK ; Mayo-Smith MF ; Ries RK ; Wilford BB (eds.) PRINCIPLES OF ADDICTION MEDICINE / 3rd ed. Chevy Chase, MD : American Society of Addiction Medicine, Inc., 1998, pp.271-285 (Chapter) [Call No: RC 564 M455 2003 [REF HAND]] [ ] | |
| 184 | Management of stimulant, hallucinogen, marijuana, phencyclidine, and club drug intoxication and withdrawal.
| |
| 185 | Exploring the relationship between race and ecstasy involvement among a sample of arrestees.
| ADAI/UW Link |
| 186 | Identifying the prevalence and correlates of ecstasy and other club drug (EOCD) use among high school seniors.
| ADAI/UW Link |
| 187 | Recommendations for future social science ecstasy research. [letter]
| UW Link |
| 188 | It's a rave new world: Estimating the prevalence and perceived harm of ecstasy and other drug use among club rave attendees.
| UW Link |
| 189 | Club drugs and sex on drugs are associated with different motivations for gay circuit party attendance in men.
| ADAI/UW Link |
| 190 | Cannabis, ecstasy/MDMA and memory: a commentary on Simon & Mattick's recent study. [letter]
| UW Link |
| 191 | Correlates of ecstasy use among students surveyed through the 1997 College Alcohol Study.
| UW Link |
| 192 | Ecstasy use among college undergraduates: gender, race and sexual identity.
| UW Link |
| 193 | Ecstasy abuse and dependence among adolescents and young adults : applicability and reliability of DSM-IV criteria.
| |
| 194 | The response to club drug use.
Maxwell JC
Curr Opin Psychiatry 2003;16:279-289 (Reprint 09080) [ ] | |
| 195 | Acute psychological and neurophysiological effects of MDMA in humans.
| |
| 196 | Estimating the prevalence of Ecstasy use among juvenile offenders.
| |
| 197 | Correlates of Ecstasy use among tenth graders surveyed through monitoring the future.
| |
| 198 | Preventing problems in Ecstasy users: reduce use to reduce harm.
| |
| 199 | Differences between Ecstasy-using and nonusing methamphetamine users.
| |
| 200 | A clinical plan for MDMA (Ecstasy) in the treatment of posttraumatic stress disorder (PTSD): partnering with the FDA.
| |
| 201 | The politics of Ecstasy.
| |
| 202 | MDMA misrepresentation: an unresolved problem for Ecstasy users.
| |
| 203 | The State of Ecstasy: MDMA--science and policy.
| |
| 204 | MDMA: a review of epidemiologic data.
| |
| 205 | Ecstasy abuse and control: hearing before the Senate Subcommittee on Governmental Affairs--July 30, 2001. Statement for the record.
| |
| 206 | Negative experiences on Ecstasy: the role of drug, set and setting.
| |
| 207 | Ecstasy: America's new "reefer madness".
| |
| 208 | Ecstasy and new patterns of drug use: a normal population study.
| UW Link |
| 209 | Heavy "ecstasy" use is associated with increased impulsivity.
| UW Link |
| 210 | Death following ingestion of MDMA (ecstasy) and moclobemide.
| UW Link |
| 211 | The effects and consequences of selected club drugs. [Review]
| UW Link |
| 212 | The content of ecstasy tablets: implications for the study of their long-term effects.
| UW Link |
| 213 | The shaman and the rave party: social pharmacology of ecstasy.
| ADAI/UW Link |
| 214 | The impact of regular ecstasy use on memory function.
| UW Link |
| 215 | Correlates of ecstasy use among high school seniors surveyed through Monitoring the Future.
Yacoubian GS
Drugs Educ Prev Policy 2003;10(1):65-72 (Journal) [ ] | ADAI/UW Link |
| 216 | Ecstasy (MDMA) deaths in New York City : a case series and review of the literature.
| |
| 217 | Mental disorders in ecstasy users: a prospective-longitudinal investigation.
| UW Link |
| 218 | Assessing the temporal relationship between race and ecstasy use among high school seniors.
| UW Link |
| 219 | 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) and driving impairment.
| |
| 220 | Use of MDMA and other illicit drugs by young adult males in northern Spain. A five-year study.
| ADAI/UW Link |
| 221 | The health effects of ecstasy: a literature review.
| UW Link |
| 222 | Ecstasy-induced psychotic disorder: six-month follow-up study.
| ADAI/UW Link |
| 223 | Using MDMA in the treatment of depression.
| |
| 224 | Ecstasy : Prescription for cultural renaissance.
Rushkoff D
In: Holland J (ed.). ECSTASY : THE COMPLETE GUIDE. Rochester, VT : Park Street Press, 2001, pp.350-357 (Chapter) [Call No: RM 666 M35 E37 2001] [ ] | |
| 225 | MDMA and spirituality : An interview with Rabbi Zalman Schachter.
Schacter Z
In: Holland J (ed.). ECSTASY : THE COMPLETE GUIDE. Rochester, VT : Park Street Press, 2001, pp.358-368 (Chapter) [Call No: RM 666 M35 E37 2001] [ ] | |
| 226 | Minimizing risk in the dance community : An interview with Emanual Sferios.
Sferios E
In: Holland J (ed.). ECSTASY : THE COMPLETE GUIDE. Rochester, VT : Park Street Press, 2001, pp.159-176 (Chapter) [Call No: RM 666 M35 E37 2001] [ ] | |
| 227 | The godparents of MDMA : An interview with Ann and Sasha Shulgin.
| |
| 228 | Does MDMA cause brain damage?
| |
| 229 | Table I : Studies of long-term behavioral or functional changes after MDMA in animals.
| |
| 230 | Table II : Reported neurofunctional differences between ecstasy users and nonusers.
| |
| 231 | Using MDMA in the treatment of post-traumatic stress disorder.
Bouso JC
In: Holland J (ed.). ECSTASY : THE COMPLETE GUIDE. Rochester, VT : Park Street Press, 2001, pp.248-260 (Chapter) [Call No: RM 666 M35 E37 2001] [ ] | |
| 232 | What does MDMA feel like?
Bravo G
In: Holland J (ed.). ECSTASY : THE COMPLETE GUIDE. Rochester, VT : Park Street Press, 2001, pp.21-28 (Chapter) [Call No: RM 666 M35 E37 2001] [ ] | |
| 233 | MDMA's promise as a prescription medicine : an interview with Rick Doblin, Ph.D.
Doblin R
In: Holland J (ed.). ECSTASY : THE COMPLETE GUIDE. Rochester, VT : Park Street Press, 2001, pp.369-386 (Chapter) [Call No: RM 666 M35 E37 2001] [ ] | |
| 234 | Giving MDMA to human volunteers in Switzerland.
| |
| 235 | Clinical experience with MDMA-assisted psychotherapy ; An interview with George Greer, M.D.
Greer G
In: Holland J (ed.). ECSTASY : THE COMPLETE GUIDE. Rochester, VT : Park Street Press, 2001, pp.222-242 (Chapter) [Call No: RM 666 M35 E37 2001] [ ] | |
| 236 | Giving MDMA to human volunteers in the United States : An interview with Charles Grob, M.D.
Grob C
In: Holland J (ed.). ECSTASY : THE COMPLETE GUIDE. Rochester, VT : Park Street Press, 2001, pp.328-343 (Chapter) [Call No: RM 666 M35 E37 2001] [ ] | |
| 237 | Medical risks associated with MDMA use.
| |
| 238 | The history of MDMA.
Holland J
In: Holland J (ed.). ECSTASY : THE COMPLETE GUIDE. Rochester, VT : Park Street Press, 2001, pp.11-20 (Chapter) [Call No: RM 666 M35 E37 2001] [ ] | |
| 239 | MDMA myths and rumors dispelled.
Holland J
In: Holland J (ed.). ECSTASY : THE COMPLETE GUIDE. Rochester, VT : Park Street Press, 2001, pp.54-57 (Chapter) [Call No: RM 666 M35 E37 2001] [ ] | |
| 240 | The legal status of MDMA around the world.
Holland J
In: Holland J (ed.). ECSTASY : THE COMPLETE GUIDE. Rochester, VT : Park Street Press, 2001, pp.146-158 (Chapter) [Call No: RM 666 M35 E37 2001] [ ] | |
| 241 | Using MDMA in the treatment of schizophrenia.
Holland J
In: Holland J (ed.). ECSTASY : THE COMPLETE GUIDE. Rochester, VT : Park Street Press, 2001, pp.273-285 (Chapter) [Call No: RM 666 M35 E37 2001] [ ] | |
| 242 | History timeline.
Holland J
In: Holland J (ed.). ECSTASY : THE COMPLETE GUIDE. Rochester, VT : Park Street Press, 2001, pp.388-391 (Chapter) [Call No: RM 666 M35 E37 2001] [ ] | |
| 243 | Statistics timeline.
Holland J
In: Holland J (ed.). ECSTASY : THE COMPLETE GUIDE. Rochester, VT : Park Street Press, 2001, pp.392-395 (Chapter) [Call No: RM 666 M35 E37 2001] [ ] | |
| 244 | Mental health problems associated with MDMA use.
Jansen KLR
In: Holland J (ed.). ECSTASY : THE COMPLETE GUIDE. Rochester, VT : Park Street Press, 2001, pp.87-109 (Chapter) [Call No: RM 666 M35 E37 2001] [ ] | |
| 245 | Clinical research with MDMA : A worldwide review.
| |
| 246 | How MDMA works in the brain.
| |
| 247 | Using MDMA in healing, psychotherapy, and spiritual practice.
| |
| 248 | Experience with the interpersonal psychedelics.
Naranjo C
In: Holland J (ed.). ECSTASY : THE COMPLETE GUIDE. Rochester, VT : Park Street Press, 2001, pp.208-221 (Chapter) [Call No: RM 666 M35 E37 2001] [ ] | |
| 249 | The chemistry of MDMA.
Nichols D
In: Holland J (ed.). ECSTASY : THE COMPLETE GUIDE. Rochester, VT : Park Street Press, 2001, pp.39-53 (Chapter) [Call No: RM 666 M35 E37 2001] [ ] | |
| 250 | Table III : Memory studies of ecstasy users vs. nonusers.
Sumnall H
In: Holland J (ed.). ECSTASY : THE COMPLETE GUIDE. Rochester, VT : Park Street Press, 2001, pp.402-404 (Chapter) [Call No: RM 666 M35 E37 2001] [ ] | |
| 251 | Using MDMA in alternative medicine : An interview with Andrew Weil, M.D.
Weil A
In: Holland J (ed.). ECSTASY : THE COMPLETE GUIDE. Rochester, VT : Park Street Press, 2001, pp.286-291 (Chapter) [Call No: RM 666 M35 E37 2001] [ ] | |
| 252 | Pill kick : The pursuit of "ecstasy" at techno-events.
Hitzler R
J Drug Issues 2002;32(2):459-465 (Journal) [ ] | UW Link |
| 253 | A political economy of "doves" [ecstasy].
Fitzgerald JL
Contemp Drug Probl 2002;29(1):201-239 (Journal) [ ] | UW Link |
| 254 | "Dancestasy" : Dance and MDMA use in Dutch youth culture.
| UW Link |
| 255 | Ecstasy tablet testing: A case of guilty until proven innocent?
| UW Link |
| 256 | Experimentally induced aggressive behavior in subjects with 3,4-methylenedioxy-methamphetamine ("Ecstasy") use history: Psychobiological correlates.
| UW Link |
| 257 | Behavioral psychopharmacology of MDMA and MDMA-like drugs : A review of human and animal studies.
| ADAI/UW Link |
| 258 | The subjective effects of MDMA and mCPP in moderate MDMA users.
| UW Link |
| 259 | The agony of ecstasy.
Romano R
Counselor 2002;3(1):30-34 (Journal) [ ] | |
| 260 | An exploration of the history and controversies surrounding MDMA and MDA.
| |
| 261 | The meaning of ecstasy use and clubbing to women in the late 1990s.
Hinchliff S
Int J Drug Policy 2001;12(5/6):455-468 (Journal) [ ] | UW Link |
| 262 | Alcohol, cannabis, ecstasy and cocaine : Drugs of reasoned choice amongst young adult recreational drug users in England.
| UW Link |
| 263 | Heroin smoking by "chasing the dragon" in young opiate users in Ireland: stability and associations with use to "come down" off "Ecstasy".
| UW Link |
| 264 | Ecstasy: the key to understanding problem use lies in understanding the users'social networks.
| UW Link |
| 265 | Circuit party attendance, club drug use, and unsafe sex in gay men.
| UW Link |
| 266 | Drugs and the dance music scene: a survey of current drug use patterns among a sample of dance music enthusiasts in the UK.
| UW Link |
| 267 | Patterns of recreational drug use at dance events in Edinburgh, Scotland.
| UW Link |
| 268 | Update on the ecstasy epidemic.
| ADAI/UW Link |
| 269 | The new CSAP director speaks out [re: plans for CSAP, hazards of ecstasy, and guidance for parents of teens].
| |
| 270 | Fact, fiction, and function: mythmaking and the social construction of ecstasy use.
| ADAI/UW Link |
| 271 | An "accidental" acute psychosis with ecstasy use.
| |
| 272 | 'Weddings, parties, anything. . .', a qualitative analysis of ecstasy use in Perth, Western Australia.
| UW Link |
| 273 | Heroin as evil : ecstasy users' perceptions about heroin.
| ADAI/UW Link |
| 274 | Psychobiological problems in heavy 'ecstasy' (MDMA) polydrug users.
| UW Link |
| 275 | Guest editorial : ecstasy use and dental health.
Hughes R
J Subst Use 2000;5(3):209-210 (Journal) [ ] | ADAI/UW Link |
| 276 | Speed freaks? A literature review detailing the nature and prevalence of dance drugs and driving.
| UW Link |
| 277 | Deconstructing ecstasy : the politics of MDMA research.
Grob CS
Addict Res 2000;8(6):549-588 (Journal) [ ] | ADAI/UW Link |
| 278 | Club drugs on the web.
| ADAI/UW Link |
| 279 | Impaired cognitive performance in drug free users of recreational ecstasy (MDMA).
| |
| 280 | Hair testing for "ecstasy" (MDMA) in volunteer Scottish drug users.
| UW Link |
| 281 | Other drugs of abuse: Inhalants, designer drugs, and steroids [pharmacological and clinical aspects].
| |
| 282 | Perceived risk and risk reduction among ecstasy users : the role of drug, set, and setting.
| UW Link |
| 283 | Ecstasy use and policy responses in the Netherlands.
Spruit IP
J Drug Issues 1999;29(3):653-678 (Journal) [ ] | UW Link |
| 284 | Ecstasy use at large-scale dance events in the Netherlands.
| UW Link |
| 285 | Ecstasy (MDMA) dependence.
| UW Link |
| 286 | Ecstasy use in Australia: patterns of use and associated harm.
| UW Link |
| 287 | A profile of harm-reduction practices and co-use of illicit and licit drugs amongst users of dance drugs.
Akram G ; Galt M
Drugs Educ Prev Policy 1999;6(2):215-225 (Journal) [ ] | ADAI/UW Link |
| 288 | Patterns of ecstasy use amongst club-goers on the UK 'dance scene'.
| UW Link |
| 289 | A method of conducting therapeutic sessions with MDMA.
| |
| 290 | Validating the consumption of MDMA (3,4-Methylenedioxymethamphetamine) in an examination of the behavioural effects of "ecstasy" amongst recreational users.
| ADAI/UW Link |
| 291 | Raves, drugs, dealing and driving : qualitative data from a West Australian sample.
| UW Link |
| 292 | Three cases of delirium after "ecstasy" ingestion.
| |
| 293 | MDMA, ketamine, GHB, and the "Club Drug" scene [treatment].
McDowell DM
In: Galanter M ; Kleber HD (eds.) TEXTBOOK OF SUBSTANCE ABUSE TREATMENT, SECOND EDITION. Washington, DC : American Psychiatric Press, Inc., 1999, pp. 295-305 (Chapter) [Call No: RC 564 A525 1999 [REF HAND]] [ ] | |
| 294 | Ecstasy.
| |
| 295 | An association between the regular use of 3,4 methylenedioxy-methamphetamine (ecstasy) and excessive wear of the teeth.
| UW Link |
| 296 | MDMA ('ecstasy') consumption in the context of polydrug abuse: a report on 150 patients.
| UW Link |
| 297 | Alcohol, drug use and sexual behaviour of young adults on a Mediterranean dance holiday.
| ADAI/UW Link |
| 298 | Raves, drugs and experience: drug use by a sample of people who attend raves in Western Australia.
| UW Link |
| 299 | The Rave Commission - the only culture police in the Western world.
Linton M
Int J Drug Policy 1998;9(5):305-310 (Journal) [ ] | UW Link |
| 300 | Drug use in South Wales: who uses ecstasy anyway?
Pates R
J Subst Misuse 1998;3(2):82-88 (Journal) [ ] | ADAI/UW Link |
| 301 | Ecstasy: the Dutch story.
Fromberg E
J Subst Misuse 1998;3(2):89-94 (Journal) [ ] | ADAI/UW Link |
| 302 | Why do people die from taking ecstasy?
Jones C
J Subst Misuse 1998;3(2):95-97 (Journal) [ ] | ADAI/UW Link |
| 303 | How the media report ecstasy.
Saunders N
J Subst Misuse 1998;3(2):98-100 (Journal) [ ] | ADAI/UW Link |
| 304 | Dancing with danger [raves and ecstasy].
Morelock JL
Student Assist J 1997;10(1):14-17 (Journal) [ ] | |
| 305 | MDMA toxicity: no evidence for a major influence of metabolic genotype at CYP2D6.
| UW Link |
| 306 | Chasing "ecstasy" : Use and abuse of amphetamine in the Netherlands.
van Laar MW ; Spruit IP
In: Klee H (ed.) AMPHETAMINE MISUSE : INTERNATIONAL PERSPECTIVES ON CURRENT TRENDS. Amsterdam : Harwood Academic Publishers, 1997, pp. 247-271 (Chapter) [Call No: RM 666 A493 A68 1997] [ ] | |
| 307 | Chasing the dragon: experience in Ireland and association with "Ecstasy" [letter]
| UW Link |
| 308 | MDMA research : Preliminary investigations with human subjects.
Grob C
Int J Drug Policy 1998;9(2):119-124 (Journal) [ ] | UW Link |
| 309 | Is the use of ecstasy and hallucinogens increasing?
| ADAI/UW Link |
| 310 | The teenage transition : From adolescent recreational drug use to the young adult dance culture in Britain in the mid-1990s.
| UW Link |
| 311 | Party subculture or dens of doom? An epidemiological study of rave attendance and drug use patterns among adolescent students.
| |
| 312 | Places and patterns of drug use in the Scottish dance scene.
| UW Link |
| 313 | Mood and cognitive effects of +/-3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy'): week-end 'high' followed by mid-week low.
| UW Link |
| 314 | MDMA (Ecstacy): useful information for health professionals involved in drug education programs.
| |
| 315 | Induction of Fos protein by 3,4-methylenedioxymethamphetamine (ecstasy) in rat brain : Regional differences in pharmacological manipulation.
| UW Link |
| 316 | Polydrug use at raves by a Western Australian sample.
| |
| 317 | Designer drugs.
Morgan JP
In: Lowinson JH ; Ruiz P ; Millman RB ; Langrod JG (eds.) SUBSTANCE ABUSE : A COMPREHENSIVE TEXTBOOK, THIRD EDITION. Philadelphia: Williams & Wilkins, 1997, p. 264-269 (Chapter) [Call No: RC 564 S826 1997 [REF HAND]] [ ] | |
| 318 | MDMA.
Grob CS ; Poland RE
In: Lowinson JH ; Ruiz P ; Millman RB ; Langrod JG (eds.) SUBSTANCE ABUSE : A COMPREHENSIVE TEXTBOOK, THIRD EDITION. Philadelphia: Williams & Wilkins, 1997, p. 269-275 (Chapter) [Call No: RC 564 S826 1997 [REF HAND]] [ ] | |
| 319 | Methamphetamine and methylenedioxymethamphetamine neurotoxicity: possible mechanisms of cell destruction.
| Free Link |
| 320 | Are raves drug supermarkets?
Forsyth AJM
Int J Drug Policy 1996;7(2):105-110 (Journal) [ ] | |
| 321 | The real paranoia behind ecstasy (letter).
Gibson J
Drug Alcohol Rev 1996;15(2):199 (Journal) [ ] | |
| 322 | MDMA (Ecstasy) substitutes for the ethanol discriminative cue in HAD but not LAD rats.
| UW Link |
| 323 | Ecstasy and illegal drug design : A new concept in drug use.
Forsyth AJM
Int J Drug Policy 1995;6(3):193-209 (Journal) [ ] | |
| 324 | Increasing ecstasy use among Glasgow drug injectors.
| ADAI/UW Link |
| 325 | Behavioral and developmental effects of two 3,4-methylenedioxymethamphetamine (MDMA) derivatives.
| |
| 326 | Psychedelic solutions? [LSD, ecstasy, etc.]
| |
| 327 | Discriminative stimulus properties of hallucinogens and related designer drugs.
| Free Link |
| 328 | 3,4-Methylenedioxymethamphetamine (MDMA, Ecstasy): pharmacology and toxicology in animals and humans.
| |
| 329 | Some observations on MDMA experiences induced through posthypnotic suggestion.
| |
| 330 | Mapping toxicant-induced nervous system damage with a cupric silver stain: A quantitative analysis of neural degeneration induced by 3,4-methylenedioxymethamphetamine.
| Free Link |
| 331 | MDMA (ecstasy): an old drug with new tricks.
Schuckit MA
Drug Abuse Alcohol Newsl 1994;23(2):1-4 (Journal) [ ] | |
| 332 | Fun, frission & fashion [ecstasy, lsd, amphetamines and nightclubs, raves and parties].
Henderson S
Int J Drug Policy 1993;4(3):122-129 (Journal) [ ] | |
| 333 | MDMA use in the north west of England.
McDermott P
Int J Drug Policy 1993;4(4):210-21 (Journal) [ ] | |
| 334 | Ecstasy in the United Kingdom: recreational drug use and subcultural change.
| |
| 335 | Chronic 3,4-methylenedioxymethamphetamine (MDMA) use: effects on mood and neuropsychological function?
| ADAI/UW Link |
| 336 | Recreational MDMA use in Sydney: a profile of 'Ecstasy' users and their experiences with the drug.
| UW Link |
| 337 | Ecstasy-fueled "rave" parties become dances of death for English youth.
Randall T
JAMA 1992;268(12):20-21 (Reprint 05602) [ ] | |
| 338 | Reversal of acute effects of 3,4-methylenedioxymethamphetamine in rat brain by 1-piperonylpiperazine.
| |
| 339 | The effect of adrenalectomy on MDMA-induced dopamine release in the striatum as measured by in vivo microdialysis and depletion of serotonin.
| |
| 340 | Study of 3,4-methylenedioxymethamphetamine-induced neurotoxicity in rat brain using specific in vivo binding of [3H]6-Nitroquipazine.
| |
| 341 | `Designer drugs': recognizing and managing their toxic effects.
| |
| 342 | The importance of drug self-administration studies in the analysis of abuse liability: an analysis of caffeine, nicotine, anabolic steroids, and designer drugs.
Foltin RW
Am J Addict 1992;1(2):139-149 (Journal) [ ] | ADAI/UW Link |
| 343 | Stalking the elusive designer drugs: techniques for monitoring new problems in drug abuse.
| ADAI/UW Link |
| 344 | New age seekers: MDMA use as an adjunct to spiritual pursuit.
| |
| 345 | The scheduling of MDMA ("ecstasy").
Beck J ; Rosenbaum M
In: Inciardi JA (ed.) HANDBOOK OF DRUG CONTROL IN THE UNITED STATES. New York : Greenwood Press, 1990, pp. 303-16. (Chapter) [Call No: HV 5825 H215 1990] [ ] | |
| 346 | Substance abuse: the designer drugs.
| |
| 347 | Phenylalkylamine stimulants, hallucinogens, and designer drugs.
| Free Link |
| 348 | Lack of neurotoxicity after intra-raphe micro-injections of MDMA ("ecstasy:).
| Free Link |
| 349 | Identification of metabolites of 3,4-methylenedioxymethamphetamine in rats.
| |
| 350 | Why MDMA should not have been made illegal.
| |
| 351 | Responses to i.v. L-tryptophan in MDMA users.
| Free Link |
| 352 | Comparison of the behavioral and neurochemical effects of 5,7-DHT, MDMA and D,L-fenfluramine.
| Free Link |
| 353 | Psychostimulant properties of MDMA.
| Free Link |
| 354 | Designer drugs: an overview.
Barnett G ; Rapaka RS
In: Redda KK ; Walker CA ; Barnett G (eds.) COCAINE, MARIJUANA, DESIGNER DRUGS: CHEMISTRY, PHARMACOLOGY, AND BEHAVIOR. Boca Raton, FL : CRC Press, 1989, pp. 163-174. (Chapter) [Call No: RM 315 C63 1989] [ ] | |
| 355 | Pharmacology and toxicology of MPTP: a neurotoxic by-product of illicit designer drug chemistry.
Trevor A ; Castagnoli N ; Singer TP
In: Redda KK ; Walker CA ; Barnett G (eds.) COCAINE, MARIJUANA, DESIGNER DRUGS: CHEMISTRY, PHARMACOLOGY, AND BEHAVIOR. Boca Raton, FL : CRC Press, 1989, pp. 187-200. (Chapter) [Call No: RM 315 C63 1989] [ ] | |
| 356 | Stimulus properties of hallucinogenic phenalkylamines and related designer drugs: formulation of structure-activity relationships.
| Free Link |
| 357 | Recommendations for future research on amphetamines and related designer drugs.
| Free Link |
| 358 | Studies of MDMA-induced neurotoxicity in nonhuman primates: a basis for evaluating long-term effects in humans.
| Free Link |
| 359 | Self-injection in baboons of amphetamines and related designer drugs.
| Free Link |
| 360 | Characterization of brain interactions with methylenedioxyamphetamine and methylenedioxymethamphetamine.
| Free Link |
| 361 | Effects of MDMA and MDA on brain serotonin neurons: evidence from neurochemical and autoradiographic studies.
| Free Link |
| 362 | Acute and long-term neurochemical effects of methylenedioxymethamphetamine in the rat.
| Free Link |
| 363 | Role of dopamine in the neurotoxicity induced by amphetamines and related designer drugs.
| Free Link |
| 364 | Neurochemical mechanisms involved in behavioral effects of amphetamines and related designer drugs.
| Free Link |
| 365 | Pharmacology and toxicology of amphetamine and related designer drugs.
| Free Link |
| 366 | Structure-activity relationships of MDMA-like substances.
| Free Link |
| 367 | Persistent neurochemical and structural changes in rat brain after oral administration of MDMA.
| |
| 368 | Ecstasy and the oxygen of publicity.
Farrell M
Br J Addict 1989;84(8):943 (Journal) [ ] | UW Link |
| 369 | New perspectives on MDMA (3,4-methylenedioxymethamphetamine).
| |
| 370 | Designer drugs : medical aspects and clinical management.
Stanford MW
Alcohol Treat Q 1987;4(4):97-125 (Journal) [ ] | |
| 371 | Relative insensitivity of mice to 3,4-methylenedioxymethamphetamine (MDMA) neurotoxicity.
|
